CD8A and neoplasm: In addition, mast cells contribute to increased chemotherapy and radiotherapy resistance (Xie et al., 2016), while tumor infiltrating CD8+ T cells are–similar to ovarian cancers or other ‘hot’ tumors–associated with improved clinical outcome (Yanai et al., 2021; Yang et al., 2021).